Lv11
24 积分 2024-09-12 加入
Upadacitinib as induction and maintenance therapy for moderately to severely active ulcerative colitis: results from three phase 3, multicentre, double-blind, randomised trials
17天前
已完结
Immune activation in irritable bowel syndrome: what is the evidence?
1个月前
已完结
Gastrointestinal effects of GLP-1 receptor agonists: mechanisms, management, and future directions
1个月前
已完结
Characterisation of MRGPRX2+mast cells in irritable bowel syndrome
1个月前
已完结
Single-center Experience With Upadacitinib for Adolescents With Refractory Inflammatory Bowel Disease
8个月前
已关闭
皖公网安备34019202002308
